HMG-COA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture

Kidney International

Volumn 52, Issue 4, 1997, Pages 962-972

  Iimura, Osamu ^a   Vrtovsnik, François ^a   Terzi, Fabiola ^a   Friedlander, Gérard ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Cell death; HMG CoA reductase inhibitors; Isoprenoid production

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CHOLESTEROL; CYTOCHALASIN D; DNA FRAGMENT; INTERLEUKIN 1BETA; ISOPRENOID; PROTEINASE INHIBITOR; UBIQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DNA DETERMINATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0030756646     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.418     Document Type: Article

References (47)

1. FICK GM, GABOW PA: Hereditary and acquired cystic diseases of the kidney. (Editorial Review) Kidney Int 46:951-964, 1994
2. MILLER LR, SOFFER O, NASSAR VH, KUTNER MH: Acquired renal cystic disease in end-stage renal disease: An autopsy study of 155 cases. Am J Nephrol 9:322-331, 1989
3. GRANTHAM JJ: Acquired cystic kidney disease. Kidney Int 40:143-152, 1991
4. GRANTHAM JJ, GEISER JL, EVAN AP: Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31:1145-1152, 1987
5. GREGOIRE JR, TORRES VE, HOLLEY KE, FARROW GM: Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kid Dis 9:27-38, 1987
6. WILSON PD: Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease. Am J Kid Dis 17:634-637, 1991
7. TRUDEL M, D'AGATI V, COSTANTINI F: c-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 39:665-671, 1991
8. WOO DDL, MLAO SYP, PELAYO JC, WOOLF AS: Taxol inhibits progression of congenital polycystic kidney disease. Nature 368:750-753, 1994
9. GILE RD, COWLEY BD, GATTONE VH II, O'DONNELL MP, SWAN SK, GRANTHAM JJ: Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat. Am J Kid Dis 26:501-507, 1995
10. GOLDSTEIN JL, BROWN MS: Regulation of the mevalonate pathway. Nature 343:425-430, 1990
11. CORSINI A, MAGGI FM, CATAPANO AL: Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31:9-27, 1995
12. MASSY ZA, GUIJARRO C, KASISKE BL: Plasma mevalonate and its importance in nephrology. Nephrol Dial Transplant 9:1716-1718, 1994
13. MCDONNEL MP, KASISKE BL, KIM Y, ATLURU D, KEANE WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 91:83-87, 1993
14. HAN Z, WYCHE JH: Lovastatin induces apoptosis in a metastatic ovarian tumor cell line. Cell Death and Differentiation 3:223-228, 1996
15. REEDOUIST KA, POPE TK, ROESS DA: Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells. Biochem Biophys Res Commun 211:665-670, 1995
16. JONES KD, COULDWELL WT, HINTON DR, SU H, HE S, ANKER L, LAW RE: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 205:1681-1687, 1994
17. PÉREZ-SALA D, MOLLINEDO F: Inhibition of isoprenoid biosynthesis induces apoptosis in human promyeolocytic HL-60 cells. Biochem Biophy Res Commun 199:1209-1215, 1994
18. DECLUE JE, VASS WC, PAPAGEORGE AG, LOWY DR, WILLUMSEN BM: Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res 51:712-717, 1991
19. MALTESE WA: Posttranslational modification of proteins by isoprenoids in mammalian cells. FASB J 4:3319-3328, 1990
20. SCHAFER WR, KIM R, STERNE R, THORNER J, KIM S-H, RINE J: Genetic and pharmacological suppression of oncogenic mutations in ras genes in yeast and humans. Science 245:379-385, 1989
21. GRÜNLER J, ERICSSON J, DALLNER G: Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta 1212:259-277, 1994
22. RIDLEY AJ, HALL A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399, 1992
23. NOBES CD, HALL A: Rho, rac, and cdc42GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia, Cell 81:53-62, 1995
24. MIURA Y, KIKUCHI A, MUSHA T, KURODA S, YAKU H, SASAKI T, TAKAI Y: Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in Swiss 3T3 cells. J Biol Biochem 268:510-515, 1993
25. FENTON RG, KUNG H, LONGO DL, SMITH MR: Regulation of intracellular actin polymerization by prenylated cellular proteins. J Cell Biol 117:347-356, 1992
26. VOGT A, QIAN Y, MCGUIRE TF, HAMILTON AD, SEBTI SM: Protein geranylgeranylation, not farnesylation, is required for the G1to S phase transition in mouse fibroblasts. Oncogene 13:1991-1999, 1996
27. RE F, ZANETTI A, SIRONI M, POLENTARUTTI N, LANFRANCONE L, DEJANA E, COLOTTA F: Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 127:537-546, 1994
28. LEVEE MG, DABROWSKA MI, LELLI JL, HINSHAW DB: Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 271:C1981-C1992, 1996
29. WATER BV, KRUIDERING M, NAGELKERKE JF: F-actin disorganization in apoptotic cell death of cultured rat renal proximal tubular cells. Am J Physiol 270:F593-F603, 1996
30. KITA T, BROWN MS, GOLDSTEIN JL: Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest 66:1094-1100, 1980
31. VINAY P, GOUGOUX A, LEMIEUX G: Isolation of a pure suspension of rat proximal tubules. Am J Phsiol 241:F403-F411, 1981
32. FRIEDLANDER G, AMIEL C: Protein kinase C activation has dissimilar effects on sodium-coupled uptakes in renal proximal tubular cells in primary culture. J Biol Chem 264:3935-3941, 1989
33. MENNA C, VRTOVSNIK F, FRIEDLANDER G, CORVOL M, GARABÉDIAN M: Insluin-like growth factor I, a unique calcium-dependent stimulator of 1.25-dihydroxyvitamine D3 production. J Biol Chem 270:25461-25467, 1995
34. SELLINS KS, COHEN JJ: Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139:3199-3206, 1987
35. DUKE RC, CHERVENAK R, COHEN JJ: Endogenous endonucleaseinduced DNA fragmentation: An early event in cell-mediated cytolysis. Proc Natl Acad Sci USA 80:6361-6365, 1983
36. GIBBS JB, POMPLIANO DL, MOSSER SD, RANDS E, LINGHAM RB, SINGH SB, SCOLNICK EM, KOHL NE, OLIFF A: Selective inhibition of farnesylprotein transferase blocks ras processing in vivo. J Biol Chem 268:7617-7620, 1993
37. POMPLIANO DL, RANDS E, SCHABER MD, MOSSER SD, ANTHONY NJ, GIBBS JB: Steady-state kinetic mechanism of ras farnesyl:protein transferase. Biochemistry 31:3800-3807, 1992
38. CROWELL PL, CHANG RR, REN Z, ELSON CE, GOULD MN: Selective inhibition of isoprcnylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266:17679-17685, 1991
39. ESTES JE, SELDEN LA, GERSHMAN LC: Mechanism of action of phalloidin on the polymerization of muscle actin. Biochemistry 20: 708-712, 1981
40. COOPER JA: Effects of cytochalasin and phalloidin on actin. J Cell Biol 105:1473-1478, 1987
41. KAYALAR C, ORD T, TESTA MP, ZHANG L, BREDESEN DE: Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 93:2234-2238, 1996
42. THORNBERRY NA, BULL HG, CALAYCAY JR, CHAPMAN KT, HOWARD AD, KOSTURA MJ, MILLER DK, MOLINEAUX SM, WEIDNER JR, AUNINS J, ELLISTON KO, AYALA JM, CASANO FJ, GLORIA JC, CHIN J, DING GJF, EGGER LA, GAFFNEY EP, LIMJUCO G, PALYHA OC, RAJU SM, ROLANDO AM, SALLEY JP, YAMIN TT, LEE TD, SHIVELY JE, MACCROSS M, MUMFORD RA, SCHMIDT JA, TOCCI MJ: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768-774, 1992
43. TAKEDA M, KOBAYASHI M, ENDOU H: Interleukin-1β converting enzyme family is involved in cisplatin-induced apoptosis in mouse proximal straight tubule cell line. (abstract) J Am Soc Nephrol 7:1847, 1996
44. NICOHOLSON DW, ALI A, THORNBERRY NA, VAILLANCOURT JP, DING CK, GALLANT M, GAREAU Y, GRIFFIN PR, LABELLE M, LAZEBNIK YA, MUNDAY NA, RAJU SM, SMULSON ME, YAMIN TT, YU VL, MILLER DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995
45. KOLBER MA, BROSCHAT KO, LANDA-GONZALEZ B: Cytochalasin B induces cellular DNA fragmentation. FASEB J 4:3021-3027, 1990
46. PEITSCH MC, POLZAR B, STEPHAN H, CROMPTON T, MACDONALD HR, MANNHERZ HG, TSCHOPP J: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programed cell death). EMBO J 12:371-377, 1993
47. KABSCH W, MANNHERZ HG, SUCK D, PAI EF, HOLMES KC: Atomic structure of the actin:DNase I complex. Nature 347:37-44, 1990